PillRx only · Tablet, Extended Release · Oral
Orphenadrine Citrate
Orphenadrine Citrate
11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
11 active makers
11 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.462
Latest avg · Jul 22, 2026
+7%
Since Dec 17, 2025
11
Active US suppliers
42%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
29K
Rx · 2026 Q1
1.0M
Units dispensed
-12%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it11 active · 3 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 13 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 7 | SUPPLYING |
| Proficient Rx LP | unknown | 7 | SUPPLYING |
| PD-Rx Pharmaceuticals, Inc. | unknown | 4 | SUPPLYING |
| ADVANCED RX PHARMACY OF TENNESSEE, LLC | unknown | 4 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 3 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 3 | SUPPLYING |
| A-S Medication Solutions | unknown | 3 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| Northwind Health Company, LLC | unknown | 1 | SUPPLYING |
| St. Mary's Medical Park Pharmacy | unknown | 1 | SUPPLYING |
| Redpharm Drug | unknown | 1 | EXITED 2027 |
| Sandoz Inc | unknown | 1 | EXITED 2027 |
| Quality Care Products, LLC | unknown | 1 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 21, 2022RECALLRecall (Class II): Orphenadrine Citrate Extended-Release Tablets, USP 100 mg, Rx Only, 100 Tablets, Manufactured by Sandoz Inc., Princeton…
CGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily limit. — Recalling firm: Sandoz, Inc — Nationwide
- Jul 11, 2014RECALLRecall (Class III): Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (N…
Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing. — Recalling firm: Sandoz Inc — Nationwide